International Journal of Clinical Research

Objective To analyze the specific effect of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods 147 patients with coronary heart disease treated in our hospital from January 2021 to January 2022 were reviewed. 74 patients treated with trimetazidine alone were classified as the control group, and 73 patients treated with atorvastatin combined with trimetazidine were classified as the observation group according to different treatment methods. The cardiac function indexes and disease recurrence of patients with coronary heart disease after treatment were observed and compared between the two groups, and their adverse reactions and final treatment satisfaction were scored and compared. Results The cardiac function index of the observation group was better than that of the control group, the recurrence time and frequency were less than that of the control group, the incidence of common adverse reactions were lower than that of the control group, and the final treatment satisfaction was higher than that of the control group, with statistical significance (P < 0.05). Conclusion Atorvastatin combined with trimetazidine is effective in the treatment of patients with coronary heart disease, which can improve the cardiac function status of patients, effectively control the onset of the disease, reduce adverse reactions, and enhance treatment satisfaction. It is of great value in clinical treatment.

Atorvastatin; Trimetazidine; Combination therapy; Coronary heart disease; Effect